98%
921
2 minutes
20
Background: Antimicrobial resistance (AMR), which refers to the ability of pathogenic bacteria to withstand the effects of antibiotics, is a critical global health issue. Traditional methods for identifying AMRs in clinical settings rely on in-lab testing, which hampers timely medical decision-making. Moreover, there is a notable delay in updating empirical treatment guidelines in response to the rapid evolution of pathogens. Recent advances in AMR research have illuminated the potential of machine learning-based patient information analysis using electronic health records (EHRs).
Methods: Against this backdrop, our study introduces a novel deep learning framework designed to leverage EHR data for generating AMR recommendations. This framework is anchored in three critical innovations. Firstly, we employ a deep graph neural network to model the correlations between various medical events, using structural information to enhance the representation of binary medical events. Secondly, in acknowledgment of the commonalities in pathogen evolution among populations, we incorporate population-level observation by modeling patient graphical structures. This strategy also addresses the issue of imbalance in rare AMR labels. Finally, we adopt a multi-task learning strategy, enabling simultaneous recommendations on multiple AMRs. Extensive experimental evaluations on a large dataset of over 110,000 patients with urinary tract infections validate the superiority of our approach.
Results: It achieves notable improvements in areas under receiver operating characteristic curves (AUROCs) for four distinct AMR labels, with increments of 0.04, 0.02, 0.06, and 0.10 surpassing the baselines.
Conclusions: Further medical analysis underscores the efficacy of our approach, demonstrating the potential of EHR-based systems in AMR recommendation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cmpb.2025.108616 | DOI Listing |
Emerg Med Australas
October 2025
Emergency and Trauma Centre, The Alfred Hospital, Melbourne, Victoria, Australia.
Objectives: Acute pyelonephritis (APN) is a common diagnosis among patients presenting to the Emergency Department (ED). It is treated by empiric antibiotics within the ED. With a rise in antimicrobial resistance globally, it is unknown whether patients are being managed with empiric antibiotics that are appropriate for the causative organisms of APN.
View Article and Find Full Text PDFMicrob Drug Resist
September 2025
Drug Discovery Research, Wockhardt Research Centre, Wockhardt Ltd., Chhatrapati Sambhajinagar, India.
Cefepime (FEP), a fourth-generation cephalosporin combined with tazobactam (TAZ), a β-lactamase inhibitor, is being developed by Wockhardt as a pharmacodynamically optimized fixed dose combination (FEP-2 g + TAZ-2 g) for the treatment of multidrug-resistant Gram-negative infections. To undertake an exposure-response analysis for establishing pharmacokinetic (PK)/pharmacodynamic (PD) targets, it is crucial to characterize the PK profile of compounds in surrogate compartments, such as plasma and lung, in clinically relevant animal infection models used to evaluate efficacy. In the current study, PKs of FEP and TAZ were assessed in plasma and in epithelial lining fluid (ELF) of neutropenic noninfected, lung-infected, and thigh-infected mice.
View Article and Find Full Text PDFSurg Infect (Larchmt)
September 2025
Department of Surgery, Division of Acute Care Surgery, University of Florida College of Medicine, Gainesville, Florida, USA.
Patients with traumatic injuries who develop ventilator-associated pneumonia (VAP) incur a higher risk of developing multi-drug resistance. Shorter duration of antibiotic agents for early VAP at five days may reduce antibiotic agent exposure without worsening patient outcomes. This retrospective cohort study performed at a Level I Trauma Center included adult (≥16 years old) patients with trauma diagnosed with bronchoalveolar lavage (BAL)-proven early (within four days of intubation) bacterial VAP.
View Article and Find Full Text PDFOpen Res Eur
September 2025
Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, 1870, Denmark.
Background: Innovative antibiotic discovery strategies are urgently needed to successfully combat infections caused by multi-drug-resistant bacteria.
Methods: We employed a direct screening approach to identify compounds with antimicrobial and antimicrobial helper-drug activity against Gram-positive and Gram-negative bacteria. We used this platform in two different strains of methicillin-resistant (MRSA) and aminoglycoside-resistant strains of to screen for antimicrobials compounds, which potentiate the activity of aminoglycoside antibiotics.
FASEB J
September 2025
Intensive Care Unit, Dongguan Traditional Chinese Medicine Hospital, Dongguan, Guangdong Province, China.
This study aimed to evaluate the quality of multidisciplinary team (MDT) management in healthcare-associated infection (HAI) prevention and control, as well as its impact on multidrug-resistant organism (MDRO) infections. This was a retrospective, single-center study with a small sample size. A total of 400 patients admitted to the Departments of Critical Care Medicine or Orthopedics between January 2022 and December 2023 were divided into a control group (n = 200, receiving conventional HAI management) and an experimental group (n = 200, undergoing MDT management).
View Article and Find Full Text PDF